Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 68 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Exploring the Viability of Telehealth Integration into Specialised Paediatric Palliative Care
Rebecca Toenne, Ursula Neuhaus, Maike Höcker, Annika Koch, Anke Menzel, Dirk Scharfe, Julia Geffron,Felix Reschke
International journal of palliative nursingno. 2 (2025): 58-67
Cited0Views0WOSBibtex
0
0
2021-LB: FABULINUS—A Randomized, Controlled Trial with FrexalimAB, to Assess Endogenous Insulin Secretion in New-Onset Stage 3 Type 1 Diabetes Adults and Adolescents
MICHAEL J. HALLER, BAERBEL ROTTHAEUSER, ANDRIY CHERKAS, MATHIEU COUDERT, PASCALE LABARD, MARIE BACCARA-DINET, GABOR BOKA,FELIX RESCHKE
Diabetesno. Supplement_1 (2024)
Cited0Views0Bibtex
0
0
Xq26.3 Duplication with Position Effect on SOX3 in a Family with Hypopituitarism
Arne Jahn, Birthe Zaencker,Karl Hackmann,Felix Reschke, Tim Hutschenreiter,Nataliya Di Donato,Evelin Schroeck, Wolfram Heinritz, Andreas Tzschach,Joseph Porrmann
EUROPEAN JOURNAL OF HUMAN GENETICS (2024): 529-530
Cited0Views0Bibtex
0
0
FABULINUS - A Randomized, Controlled Trial with FrexalimAB, to Assess Endogenous Insulin Secretion in New Onset Stage 3 Type 1 Diabetes in Adults and Adolescents
M. Haller, B. Rotthaeuser, A. Cherkas, M. Coudert, P. Labard, M. Baccara-Dinet, G. Boka, M. Peakman,F. Reschke
HORMONE RESEARCH IN PAEDIATRICS (2024): 113-113
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 68

#Citation: 347

H-Index: 9

G-Index: 18

Sociability: 5

Diversity: 2

Activity: 22

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn